Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose spironolactone in post-adolescent acne
TCTR20190417004Phase 4Completed
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in acne vulgaris, sponsored by Faculty of Medicine, Chulalongkorn University. Started Feb 2019; status: completed.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20190417004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190417004.